Chemours Co (CC) - Net Assets
Based on the latest financial reports, Chemours Co (CC) has net assets worth $300.00 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.57 Billion) and total liabilities ($7.27 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CC asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $300.00 Million |
| % of Total Assets | 3.96% |
| Annual Growth Rate | -13.03% |
| 5-Year Change | -25.77% |
| 10-Year Change | 365.38% |
| Growth Volatility | 207.73 |
Chemours Co - Net Assets Trend (2012–2024)
This chart illustrates how Chemours Co's net assets have evolved over time, based on quarterly financial data. Also explore Chemours Co total assets for the complete picture of this company's asset base.
Annual Net Assets for Chemours Co (2012–2024)
The table below shows the annual net assets of Chemours Co from 2012 to 2024. For live valuation and market cap data, see market cap of Chemours Co.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $605.00 Million | -18.13% |
| 2023-12-31 | $739.00 Million | -33.24% |
| 2022-12-31 | $1.11 Billion | +2.31% |
| 2021-12-31 | $1.08 Billion | +32.76% |
| 2020-12-31 | $815.00 Million | +17.27% |
| 2019-12-31 | $695.00 Million | -31.86% |
| 2018-12-31 | $1.02 Billion | +17.92% |
| 2017-12-31 | $865.00 Million | +731.73% |
| 2016-12-31 | $104.00 Million | -20.00% |
| 2015-12-31 | $130.00 Million | -96.46% |
| 2014-12-31 | $3.67 Billion | +12.02% |
| 2013-12-31 | $3.28 Billion | +1.55% |
| 2012-12-31 | $3.23 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Chemours Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 171800000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.72 Billion | 284.44% |
| Common Stock | $2.00 Million | 0.33% |
| Other Comprehensive Income | $-367.00 Million | -60.76% |
| Total Equity | $604.00 Million | 100.00% |
Chemours Co Competitors by Market Cap
The table below lists competitors of Chemours Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brederode SA
BR:BREB
|
$3.08 Billion |
|
Shurgard Self Storage SA
BR:SHUR
|
$3.08 Billion |
|
Sigma Advanced Systems Limited
NSE:MEGASOFT
|
$3.08 Billion |
|
Columbia Sportswear Company
NASDAQ:COLM
|
$3.08 Billion |
|
Hong Ri Da Technology Co. Ltd. A
SHE:301285
|
$3.08 Billion |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
$3.07 Billion |
|
Anhui Conch Cement Company Limited
F:AQE
|
$3.07 Billion |
|
Test Research Inc
TW:3030
|
$3.07 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chemours Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 737,000,000 to 604,000,000, a change of -133,000,000 (-18.0%).
- Net income of 86,000,000 contributed positively to equity growth.
- Dividend payments of 148,000,000 reduced retained earnings.
- Share repurchases of 3,000,000 reduced equity.
- Other comprehensive income decreased equity by 93,000,000.
- Other factors increased equity by 25,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $86.00 Million | +14.24% |
| Dividends Paid | $148.00 Million | -24.5% |
| Share Repurchases | $3.00 Million | -0.5% |
| Other Comprehensive Income | $-93.00 Million | -15.4% |
| Other Changes | $25.00 Million | +4.14% |
| Total Change | $- | -18.05% |
Book Value vs Market Value Analysis
This analysis compares Chemours Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.88x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.34x to 5.88x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $17.66 | $23.67 | x |
| 2013-12-31 | $17.92 | $23.67 | x |
| 2014-12-31 | $20.08 | $23.67 | x |
| 2015-12-31 | $0.70 | $23.67 | x |
| 2016-12-31 | $0.55 | $23.67 | x |
| 2017-12-31 | $4.50 | $23.67 | x |
| 2018-12-31 | $5.55 | $23.67 | x |
| 2019-12-31 | $4.18 | $23.67 | x |
| 2020-12-31 | $4.89 | $23.67 | x |
| 2021-12-31 | $6.41 | $23.67 | x |
| 2022-12-31 | $6.99 | $23.67 | x |
| 2023-12-31 | $4.95 | $23.67 | x |
| 2024-12-31 | $4.03 | $23.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chemours Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.24%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.49%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 12.44x
- Recent ROE (14.24%) is below the historical average (22.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 32.75% | 14.35% | 1.39x | 1.65x | $734.30 Million |
| 2013 | 12.91% | 6.17% | 1.22x | 1.72x | $95.40 Million |
| 2014 | 10.90% | 6.22% | 1.08x | 1.63x | $33.10 Million |
| 2015 | -71.43% | -1.57% | 0.91x | 49.98x | $-102.60 Million |
| 2016 | 7.00% | 0.13% | 0.89x | 60.60x | $-3.00 Million |
| 2017 | 86.74% | 12.07% | 0.85x | 8.48x | $660.00 Million |
| 2018 | 98.13% | 14.99% | 0.90x | 7.26x | $893.60 Million |
| 2019 | -7.55% | -0.94% | 0.76x | 10.53x | $-120.90 Million |
| 2020 | 26.94% | 4.41% | 0.70x | 8.71x | $137.70 Million |
| 2021 | 56.24% | 9.58% | 0.84x | 6.98x | $499.90 Million |
| 2022 | 52.21% | 8.46% | 0.89x | 6.90x | $467.30 Million |
| 2023 | -32.29% | -3.92% | 0.74x | 11.20x | $-311.70 Million |
| 2024 | 14.24% | 1.49% | 0.77x | 12.44x | $25.60 Million |
Industry Comparison
This section compares Chemours Co's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,483,598,555
- Average return on equity (ROE) among peers: 2.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chemours Co (CC) | $300.00 Million | 32.75% | 24.23x | $3.08 Billion |
| Albemarle Corp (ALB) | $5.81 Billion | 2.13% | 0.89x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $4.98 Million | -32.65% | 0.10x | $212.84 Million |
| Aemetis Inc (AMTX) | $-201.85 Million | 0.00% | 0.00x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $2.10 Billion | 12.92% | 1.14x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.71 Billion | 13.97% | 1.77x | $2.50 Billion |
| Avient Corp (AVNT) | $2.34 Billion | 3.24% | 1.55x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.14 Billion | 8.03% | 4.13x | $6.08 Billion |
| Balchem Corporation (BCPC) | $938.28 Million | 11.23% | 0.73x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $1.52 Million | 1.74% | 0.09x | $4.73 Million |
| Bon Natural Life Ltd (BON) | $4.55 Million | 4.91% | 2.66x | $7.17 Million |
About Chemours Co
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, … Read more